China’s COVID-19 vaccine developer Clover Biopharmaceuticals said on Thursday it raised $240 million in net proceeds in an IPO in Hong Kong.
( read original story …)
The HongKong News
China’s COVID-19 vaccine developer Clover Biopharmaceuticals said on Thursday it raised $240 million in net proceeds in an IPO in Hong Kong.
( read original story …)